These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9430448)

  • 21. Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects.
    Doga M; Bonadonna S; Burattin A; Giustina A
    Ann Oncol; 2001; 12 Suppl 2():S89-94. PubMed ID: 11762359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
    Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A re-evaluation of the prolactin-releasing activity of growth hormone-releasing hormone in acromegaly in vivo.
    Watanobe H; Tamura T
    Neuropeptides; 1995 Feb; 28(2):73-8. PubMed ID: 7746357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
    Cordido F; Peñalva A; Martinez T; Casanueva FF; Dieguez C
    Clin Endocrinol (Oxf); 2001 Apr; 54(4):509-13. PubMed ID: 11318787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.
    van der Klaauw AA; Pereira AM; van Thiel SW; Smit JW; Corssmit EP; Biermasz NR; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Eur J Endocrinol; 2006 Jun; 154(6):851-8. PubMed ID: 16728545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6.
    Popovic V; Damjanovic S; Micic D; Petakov M; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1994 Aug; 79(2):456-60. PubMed ID: 8045963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation by glucocorticoids of growth hormone secretion in patients with different pituitary tumors.
    Popovic V; Damjanovic S; Micic D; Manojlovic D; Micic J; Casanueva FF
    Neuroendocrinology; 1993 Oct; 58(4):465-72. PubMed ID: 8284031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly.
    Lamberts SW; Zweens M; Klijn JG; van Vroonhoven CC; Stefanko SZ; Del Pozo E
    Clin Endocrinol (Oxf); 1986 Aug; 25(2):201-12. PubMed ID: 2878748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel features of tumors that secrete both growth hormone and prolactin in acromegaly.
    Nyquist P; Laws ER; Elliott E
    Neurosurgery; 1994 Aug; 35(2):179-83; discussion 183-4. PubMed ID: 7969823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of theophylline infusion on the growth hormone (GH) and prolactin response to GH-releasing hormone administration in acromegaly.
    Losa M; Alba-Lopez J; Schopohl J; Sobiesczcyk S; Chiodini PG; Müller OA; von Werder K
    J Endocrinol Invest; 1988 Oct; 11(9):663-7. PubMed ID: 3146595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone and prolactin secretion in acromegaly: correlations between hormonal dynamics and immunocytochemical findings.
    Bassetti M; Arosio M; Spada A; Brina M; Bazzoni N; Faglia G; Giannattasio G
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1195-204. PubMed ID: 3142915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone releasing hormone-sensitive adenylate cyclase activity in growth hormone-producing pituitary adenoma: correlation to the response of plasma growth hormone to growth hormone releasing hormone in patients with acromegaly.
    Natori S; Ikuyama S; Haji M; Ohashi M; Nawata H
    Endocrinol Jpn; 1989 Apr; 36(2):229-36. PubMed ID: 2550207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release: studies in normal and acromegalic subjects.
    Massara F; Ghigo E; Demislis K; Tangolo D; Mazza E; Locatelli V; Müller EE; Molinatti GM; Camanni F
    Neuroendocrinology; 1986; 43(6):670-5. PubMed ID: 3093909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
    Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
    J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell.
    Beck-Peccoz P; Bassetti M; Spada A; Medri G; Arosio M; Giannattasio G; Faglia G
    J Clin Endocrinol Metab; 1985 Sep; 61(3):541-6. PubMed ID: 2410443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased growth hormone pulse frequency in acromegaly.
    Barkan AL; Stred SE; Reno K; Markovs M; Hopwood NJ; Kelch RP; Beitins IZ
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1225-33. PubMed ID: 2511221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRH is a tonic secretagogue in growth hormone secreting but not in nonfunctioning pituitary tumors.
    Somjen D; Tordjman K; Greenman Y; Kohen F; Ouaknine GE; Stern N
    J Endocrinol Invest; 1999 Feb; 22(2):104-8. PubMed ID: 10195376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.